Chamber and committees

Public Health Scotland does not publish data at the level of detail requested. However, statistics relating to the waits patients experience for inpatient or day case treatment at specialty level are published up to 31 March 2022 and can be found here: Stage of treatment waiting times - Inpatients, day cases and new outpatients 30 June 2022 - NHS waiting times - stage of treatment - Publications - Public Health Scotland

Both the Scottish Government and NHS Greater Glasgow and Clyde are aware, and regret, that patients are experiencing longer than normal delays in accessing NHS care, including at the mesh removal service in Glasgow. Patients are, however, being seen, surgeries carried out, and concerted efforts are being made to reduce waiting times.

The Complex Pelvic Mesh Service provided by NHS Greater Glasgow and Clyde (NHS GGC) offers holistic care for women experiencing mesh complications. There are a number of consultants operating in the service allowing women a choice over who is involved in their care. Complementing this, and to allow women more choice, individuals can also opt to be referred to NHS England services for surgery, or can choose to travel to Spire Hospital in Bristol, or to Dr Veronikis in the USA.

Any woman seeking referral to the mesh service in Glasgow, NHS England, Spire Hospital or Dr Veronikis should initially discuss her case with clinicians within her own Health Board. If considered appropriate at that stage, she will then be referred to the specialist service in NHS GGC for consideration by a full multi-disciplinary team (MDT). If, after careful consideration by both the MDT and the patient, it is agreed that surgery is appropriate, she will then be given the option of receiving treatment through the Glasgow centre, or referral to an NHS England Specialist Centre, the Spire in Bristol, or Dr Veronikis, depending on her wishes.

Regardless of the treatment option chosen, initial assessment in the specialist service in Glasgow is extremely important as it ensures that the patient receives the proper consideration of a full MDT, and will receive care that is fully integrated with any pre- and post-operative care provided locally.

I refer the member to the answer to question S6W-11635 on‎ 14 November 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

A number of women have been assessed at the specialist service in NHS Greater Glasgow and Clyde and have subsequently requested onward referral to the independent providers. It is the responsibility of the patient’s local Health Board to make that referral and, in a number of cases, this has already occurred whilst, in others, preparations for referral are ongoing.

Neither the Scottish Government nor NHS National Services Scotland are able to confirm specifically when any patient will travel to the USA or Bristol for treatment, as the scheduling of surgery is dependent on clinical review by the provider and their subsequent acceptance of the case in question.

In light of the small number of patients referred, it would not be appropriate to disclose exact numbers due to the potential risk to patient confidentiality.

The reimbursement scheme established under the Transvaginal Mesh Removal (Cost Reimbursement) (Scotland) Act 2022 is concerned with the reimbursement of costs associated mesh removal surgery arranged by women privately, where such arrangements were made on or before 3 June 2022. The scheme has no function in relation to the commissioning by NHS Scotland of mesh removal surgery from independent providers.

Mesh removal surgery commissioned from independent providers by NHS Scotland, in the UK or elsewhere, is arranged under Health Boards’ general powers, and there is no time limit on such arrangements being made.

I refer the member to the answer to question S6W-11633 on‎ 14 November 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

We awarded a contract through a competitive tender for independent VAT advice from Anderson Anderson & Brown LLP. AAB have been commissioned to provide advice and support to SG on VAT implications. This work is ongoing. We will engage with the wider sector and HMT prior to any decision being taken which would have a VAT impact.

Please see the details of contracts awarded to private companies to undertake work regarding the establishment of a National Care Service in the following table.

In 2022-23, funding of £18 billion is provided for health and social care. This substantial investment is already benefitting a range of services that are supporting the needs of people living with long COVID.

Health funding for 2023-24 will be confirmed through the forthcoming budget process.

We engage with NHS Boards on a regular basis regarding their capacity needs, and will continue to do so in order to inform the allocation of the long COVID Support Fund.

After competitive tender, a contract was awarded to Anderson Anderson & Brown LLP to obtain expert independent advice on the implications of VAT on the NCS and associated Care Boards. This work is ongoing. We will engage with the wider sector and HMT prior to any decision being taken which would have a VAT impact.